VYNE Therapeutics declared a special cash dividend tied to its proposed merger, placing the biotechnology company back in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results